Pacira BioSciences, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pacira BioSciences, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Pacira BioSciences, Inc. Return On Equity for the quarter ending September 30, 2024 was -10.7 %, a 1319% decline year-over-year.
  • Pacira BioSciences, Inc. annual Return On Equity for 2023 was 5.12 %, a 142% increase from 2022.
  • Pacira BioSciences, Inc. annual Return On Equity for 2022 was 2.11 %, a 64.9% decline from 2021.
  • Pacira BioSciences, Inc. annual Return On Equity for 2021 was 6.03 %, a 79.6% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -10.7 -11.6 -1319% Jul 1, 2024 Sep 30, 2024
Q2 2024 7.32 +7.91 Apr 1, 2024 Jun 30, 2024
Q1 2024 8.29 +9.65 Jan 1, 2024 Mar 31, 2024
Q4 2023 5.12 +3.01 +142% Oct 1, 2023 Dec 31, 2023
Q3 2023 0.88 -1.94 -68.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -0.59 -5.97 -111% Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.36 -6.77 -125% Jan 1, 2023 Mar 31, 2023
Q4 2022 2.11 -3.91 -64.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 2.82 -6.4 -69.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 5.38 -22 -80.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 5.4 -20.9 -79.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 6.03 -23.6 -79.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 9.21 -20.4 -68.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 27.4 +30.2 Apr 1, 2021 Jun 30, 2021
Q1 2021 26.3 +26.4 Jan 1, 2021 Mar 31, 2021
Q4 2020 29.6 +32.8 Oct 1, 2020 Dec 31, 2020
Q3 2020 29.6 +29 +4492% Jul 1, 2020 Sep 30, 2020
Q2 2020 -2.76 -5.11 -217% Apr 1, 2020 Jun 30, 2020
Q1 2020 -0.02 -2.42 -101% Jan 1, 2020 Mar 31, 2020
Q4 2019 -3.22 -3.06 -1935% Oct 1, 2019 Dec 31, 2019
Q3 2019 0.65 +2.09 Jul 1, 2019 Sep 30, 2019
Q2 2019 2.35 +6.35 Apr 1, 2019 Jun 30, 2019
Q1 2019 2.4 +14.7 Jan 1, 2019 Mar 31, 2019
Q4 2018 -0.16 +15.7 +99% Oct 1, 2018 Dec 31, 2018
Q3 2018 -1.45 +18.7 +92.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -3.99 +23.3 +85.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -12.3 +10.8 +46.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -15.8 +1.26 +7.37% Oct 1, 2017 Dec 31, 2017
Q3 2017 -20.2 -3.71 -22.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -27.3 -22.2 -436% Apr 1, 2017 Jun 30, 2017
Q1 2017 -23.2 -21.6 -1408% Jan 1, 2017 Mar 31, 2017
Q4 2016 -17.1 -18 -1958% Oct 1, 2016 Dec 31, 2016
Q3 2016 -16.5 -11.5 -234% Jul 1, 2016 Sep 30, 2016
Q2 2016 -5.09 +3.67 Apr 1, 2016 Jun 30, 2016
Q1 2016 -1.54 +10.9 +87.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 0.92 +27 Oct 1, 2015 Dec 31, 2015
Q3 2015 -4.93 +28.2 +85.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -8.76* +54.4 Apr 1, 2015 Jun 30, 2015
Q1 2015 -12.5 +100 +89% Jan 1, 2015 Mar 31, 2015
Q4 2014 -26.1 +90.5 +77.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -33.1 +78.9 +70.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -63.1 +37.5 +37.3% Apr 1, 2014 Jun 30, 2014
Q1 2014 -113 -31 -37.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -117 -41.4 -55% Oct 1, 2013 Dec 31, 2013
Q3 2013 -112 -33.4 -42.4% Jul 1, 2013 Sep 30, 2013
Q2 2013 -101 -7.86 -8.47% Apr 1, 2013 Jun 30, 2013
Q1 2013 -81.8 +66.8 +45% Jan 1, 2013 Mar 31, 2013
Q4 2012 -75.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 -78.7 Jul 1, 2012 Sep 30, 2012
Q2 2012 -92.8 Apr 1, 2012 Jun 30, 2012
Q1 2012 -149 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.